Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
- 2019 (24) (remove)
Document Type
- Journal article (22)
- Doctoral Thesis (2)
Language
- English (24) (remove)
Keywords
- deep brain stimulation (4)
- ischemic stroke (3)
- length of stenosis (3)
- HBMEC (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- blood–brain barrier (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- degree of stenosis (2)
- mesencephalic locomotor region (2)
- neuroinflammation (2)
- neurology (2)
- photothrombotic stroke (2)
- stroke (2)
- subthalamic nucleus (2)
- Affekt (1)
- Anxiety (1)
- Apoptosis (1)
- Atrial fibrillation (1)
- B7-H1 (1)
- CCI (1)
- CIDP (1)
- CXCL5 (1)
- CXCL8 (1)
- CXCR2 (1)
- Carotisstenose (1)
- Caspase (1)
- Clinically silent stroke (1)
- Cognitive behavior (1)
- Elektrophysiologie (1)
- Emotionales Verhalten (1)
- Immune system (1)
- Ischemic stroke (1)
- Meningitis (1)
- Neuroinflammation (1)
- Nucleus subthalamicus (1)
- Oral anticoagulation (1)
- Parkinson’s disease (1)
- SB332235 (1)
- Schlaganfall (1)
- Secondary stroke prevention (1)
- Stenosis degree (1)
- Stenosis length (1)
- Stroke unit (1)
- Survey (1)
- TDMT (1)
- White matter lesions (1)
- aging (1)
- anti-contactin-1 (1)
- atrial fibrillation (1)
- autoantibody (1)
- bilateral internal carotid artery stenosis (1)
- blood-brain barrier (1)
- brain networks (1)
- cerebral microbleeds (1)
- cervical dystonia (1)
- clinical outcome (1)
- complement deposition (1)
- continuous theta burst stimulation (cTBS) (1)
- cortical excitability (1)
- cortical silent period (1)
- dopamine (1)
- dystonia (1)
- emotion (1)
- fibromyalgia (1)
- functional MRI (1)
- functional connectivity (1)
- glycoprotein VI (1)
- hemicraniectomy (1)
- human cerebral endothelial cells (1)
- hypothermia (1)
- integrin α2 (1)
- interleukin-8 (1)
- internal carotid artery stenosis (1)
- intracranial bleeding (1)
- kinesthesia (1)
- liponeurocytoma (1)
- local field potentials (1)
- magnetic resonance imaging (1)
- medulloblastoma (1)
- meningitis (1)
- molecular signature (1)
- motor-evoked potentials (MEP) (1)
- movement (1)
- multiple sclerosis (1)
- neurocytoma (1)
- neuronal apoptosis (1)
- neuroprotection (1)
- oscillations (1)
- outcome (1)
- paranodopathy (1)
- passive transfer (1)
- plaque cross-sectional area (1)
- pointing task (1)
- position estimation (1)
- recombinant tissue-type plasminogen activator (1)
- somatosensory temporal discrimination (1)
- temporal discrimination threshold (1)
- tight junctions (1)
- transcranial magnetic simulation (TMS) (1)
- transient ischemic attack (1)
- transient middle cerebral artery occlusion (1)
- white matter lesions (1)
Institute
- Neurologische Klinik und Poliklinik (24) (remove)
Symptomatic vs. asymptomatic 20–40% internal carotid artery stenosis: Does the plaque size matter?
(2019)
Background: Around 9–15% of ischemic strokes are related to internal carotid artery (ICA)-stenosis ≥50%. However, the extent to which ICA-stenosis <50% causes ischemic cerebrovascular events is uncertain. We examined the relation between plaque cross-sectional area and length and the risk of ischemic stroke or TIA among patients with ICA-stenosis of 20–40%.
Methods: We retrospectively identified patients admitted to the Department of Neurology, University Hospital of Würzburg, from January 2011 until September 2016 with ischemic stroke or TIA and concomitant ICA-stenosis of 20–40%, either symptomatic or asymptomatic. Plaque length and cross-sectional area were assessed on ultrasound scans.
Results: We identified 41 patients with ischemic stroke or TIA and ICA-stenosis of 20–40%; 14 symptomatic and 27 asymptomatic. The plaque cross-sectional area was significantly larger among symptomatic than asymptomatic ICA-stenosis; median values (IQR) were 0.45 (0.21–0.69) cm2 and 0.27 (0.21–0.38) cm2, p = 0.03, respectively. A plaque cross-sectional area ≥0.36 cm2 had a sensitivity of 71% and a specificity of 76% for symptomatic compared with asymptomatic ICA-stenosis. In a sex-adjusted multivariate logistic regression, a plaque cross-sectional area ≥0.36 cm2 and a plaque length ≥1.65 cm were associated with an OR (95% CI) of 5.54 (1.2–25.6), p = 0.028 and 1.78 (0.36–8.73), p = 0.48, respectively, for symptomatic ICA-stenosis.
Conclusion: Large plaques might increase the risk of ischemic stroke or TIA among patients with low-grade ICA-stenosis of 20–40%. Sufficiently powered prospective longitudinal cohort studies are needed to definitively test the stroke risk stratification value of carotid plaque length and cross-sectional area in the setting of current optimal medical treatment.
Platelet collagen interactions at sites of vascular injuries predominantly involve glycoprotein VI (GPVI) and the integrin α2β1. Both proteins are primarily expressed on platelets and megakaryocytes whereas GPVI expression is also shown on endothelial and integrin α2β1 expression on epithelial cells. We recently showed that depletion of GPVI improves stroke outcome without increasing the risk of cerebral hemorrhage. Genetic variants associated with higher platelet surface integrin α2 (ITGA2) receptor levels have frequently been found to correlate with an increased risk of ischemic stroke in patients. However until now, no preclinical stroke study has addressed whether platelet integrin α2β1 contributes to the pathophysiology of ischemia/reperfusion (I/R) injury. Focal cerebral ischemia was induced in C57BL/6 and Itga2\(^{−/−}\) mice by a 60 min transient middle cerebral artery occlusion (tMCAO). Additionally, wild-type animals were pretreated with anti-GPVI antibody (JAQ1) or Fab fragments of a function blocking antibody against integrin α2β1 (LEN/B). In anti-GPVI treated animals, intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment was applied immediately prior to reperfusion. Stroke outcome, including infarct size and neurological scoring was determined on day 1 after tMCAO. We demonstrate that targeting the integrin α2β1 (pharmacologic; genetic) did neither reduce stroke size nor improve functional outcome on day 1 after tMCAO. In contrast, depletion of platelet GPVI prior to stroke was safe and effective, even when combined with rt-PA treatment. Our results underscore that GPVI, but not ITGA2, is a promising and safe target in the setting of ischemic stroke.
Background
Increasing attention is payed to the contribution of somatosensory processing in motor control. In particular, temporal somatosensory discrimination has been found to be altered differentially in common movement disorders. To date, there have only been speculations as to how impaired temporal discrimination and clinical motor signs may relate to each other. Prior to disentangling this relationship, potential confounders of temporal discrimination, in particular age and peripheral nerve conduction, should be assessed, and a quantifiable measure of proprioceptive performance should be established.
ObjectiveTo assess the influence of age and polyneuropathy (PNP) on somatosensory temporal discrimination threshold (STDT), temporal discrimination movement threshold (TDMT), and behavioral measures of proprioception of upper and lower limbs.
Methods
STDT and TDMT were assessed in 79 subjects (54 healthy, 25 with PNP; age 30–79 years). STDT was tested with surface electrodes over the thenar or dorsal foot region. TDMT was probed with needle electrodes in flexor carpi radialis (FCR) and tibialis anterior (TA) muscle. Goniometer-based devices were used to assess limb proprioception during (i) active pointing to LED markers, (ii) active movements in response to variable visual cues, and (iii) estimation of limb position following passive movements. Pointing (or estimation) error was taken as a measure of proprioceptive performance.
Results
In healthy subjects, higher age was associated with higher STDT and TDMT at upper and lower extremities, while age did not correlate with proprioceptive performance. Patients with PNP showed higher STDT and TDMT values and decreased proprioceptive performance in active pointing tasks compared to matched healthy subjects. As an additional finding, there was a significant correlation between performance in active pointing tasks and temporal discrimination thresholds.
Conclusion
Given their notable impact on measures of temporal discrimination, age and peripheral nerve conduction need to be accounted for if STDT and TDMT are applied in patients with movement disorders. As a side observation, the correlation between measures of proprioception and temporal discrimination may prompt further studies on the presumptive link between these two domains.
Ureaplasma species are common colonizers of the adult genitourinary tract and often considered as low-virulence commensals. Intraamniotic Ureaplasma infections, however, facilitate chorioamnionitis and preterm birth, and cases of Ureaplasma-induced neonatal sepsis, pneumonia, and meningitis raise a growing awareness of their clinical relevance. In vitro studies are scarce but demonstrate distinct Ureaplasma-driven impacts on immune mechanisms. The current study addressed cytokine and chemokine responses upon exposure of native or lipopolysaccharide (LPS) co-stimulated human brain microvascular endothelial cells (HBMEC) to Ureaplasma urealyticum or U. parvum, using qRT-PCR, RNA sequencing, multi-analyte immunoassay, and flow cytometry. Ureaplasma exposure in native HBMEC reduced monocyte chemoattractant protein (MCP)-3 mRNA expression (p < 0.01, vs. broth). In co-stimulated HBMEC, Ureaplasma spp. attenuated LPS-evoked mRNA responses for C-X-C chemokine ligand 5, MCP-1, and MCP-3 (p < 0.05, vs. LPS) and mitigated LPS-driven interleukin (IL)-1α protein secretion, as well as IL-8 mRNA and protein responses (p < 0.05). Furthermore, Ureaplasma isolates increased C-X-C chemokine receptor 4 mRNA levels in native and LPS co-stimulated HBMEC (p < 0.05). The presented results may imply immunomodulatory capacities of Ureaplasma spp. which may ultimately promote chronic colonization and long-term neuroinflammation.